A detailed history of Bank Of Montreal transactions in Geron Corp stock. As of the latest transaction made, Bank Of Montreal holds 23,369 shares of GERN stock, worth $99,785. This represents 0.0% of its overall portfolio holdings.

Number of Shares
23,369
Previous 23,507 0.59%
Holding current value
$99,785
Previous $77,000 28.57%
% of portfolio
0.0%
Previous 0.0%

Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$3.1 - $5.09 $427 - $702
-138 Reduced 0.59%
23,369 $99,000
Q1 2024

May 13, 2024

SELL
$1.75 - $3.44 $78,680 - $154,662
-44,960 Reduced 65.67%
23,507 $77,000
Q4 2023

Feb 08, 2024

BUY
$1.74 - $2.31 $1,186 - $1,575
682 Added 1.01%
68,467 $144,000
Q3 2023

Nov 01, 2023

BUY
$2.11 - $3.28 $70,083 - $108,945
33,215 Added 96.08%
67,785 $143,000
Q2 2023

Aug 02, 2023

BUY
$1.97 - $3.69 $68,102 - $127,563
34,570 New
34,570 $110,000
Q1 2023

Jun 13, 2024

SELL
$2.14 - $3.4 $8,542 - $13,572
-3,992 Reduced 16.98%
19,515 $42,000
Q2 2022

Aug 11, 2022

BUY
$1.19 - $1.65 $9,030 - $12,521
7,589 New
7,589 $11,000

Others Institutions Holding GERN

About GERON CORP


  • Ticker GERN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 377,819,008
  • Market Cap $1.61B
  • Description
  • Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...
More about GERN
Track This Portfolio

Track Bank Of Montreal Portfolio

Follow Bank Of Montreal and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Bank Of Montreal , based on Form 13F filings with the SEC.

News

Stay updated on Bank Of Montreal with notifications on news.